Physician

Tarek Nabil El-Sherif, MD

According to 2025 Medicare claims, Tarek El-Sherif, MD (NPI: 1073538807) practices cardiology in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is PADDER HEALTH SERVICES, LLC (NPI: 1447426895; TIN: 261731563) and primary practice location at 21742-6727. El-Sherif is affiliated with the Aledade A2557 DE MSSP Enhanced (ACO ID: A2557) and ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

El-Sherif's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,106 traditional Medicare patients, billed 6,123 HCPCS/CPT codes, and received $412,046 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,634 prescription claims across 599 beneficiaries totaling $1,211,992 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 53 records totaling $822. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $177,488 to $1,211,992. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,618	4,505	$318,648
2016	1,818	4,633	$300,611
2017	1,959	4,879	$301,012
2018	2,251	5,949	$398,375
2019	1,916	5,432	$363,624
2020	2,076	5,431	$354,255
2021	2,298	5,766	$365,443
2022	1,841	4,720	$323,354
2023	1,495	4,100	$290,267
2024	2,106	6,123	$412,046

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	1,606	$177,488
2016	224	1,248	$126,566
2017	255	1,113	$95,484
2018	298	1,548	$172,995
2019	310	1,573	$220,952
2020	356	2,165	$346,109
2021	428	3,495	$696,120
2022	469	3,641	$824,335
2023	525	3,881	$981,188
2024	599	4,634	$1,211,992

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	408	427	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	987	1,625	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	181	205	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	735	803	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	922	1,153	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	433	26,513	$492,521
Xarelto	Rivaroxaban	155	10,380	$188,552
Entresto	Sacubitril/Valsartan	95	7,125	$146,661
Farxiga	Dapagliflozin Propanediol	57	4,720	$81,293
Jardiance	Empagliflozin	61	4,050	$76,385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$822	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tarek Nabil El-Sherif, MD?

Tedicare shows public-source Medicare data for Tarek Nabil El-Sherif, MD (NPI 1073538807), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tarek Nabil El-Sherif, MD have ACO affiliation data?

Tarek Nabil El-Sherif, MD is shown with ACO affiliation data for Aledade A2557 DE MSSP Enhanced (MSSP, ACO ID A2557) and ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Tarek Nabil El-Sherif, MD?

Tarek Nabil El-Sherif, MD is linked to PADDER HEALTH SERVICES, LLC (billing NPI 1447426895) in the available physician profile data.

Does Tarek Nabil El-Sherif, MD have Open Payments data?

Tarek Nabil El-Sherif, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.